Works matching DE "HER2 gene"

Results: 913

Clinical significance of HER2 overexpression in biliary tract carcinoma ——a meta analysis.

Published in:

Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1534005

By:

Xu, Haonan;
Liang, Yuwen;
Tang, Wenqiang;
Yang, Xiongxin;
Du, Xiaobo

Publication type:

Article

A Perimenopausal Woman With a Small, ER/HER2-Positive, Node-Negative Breast Cancer.

Published in:

Oncology (08909091), 2008, v. 22, n. 11, p. 1270

By:

Brooks, Gabriel;
Borges, Virginia;
Singh, Meenakshi;
Rabinovitch, Rachel;
Finlayson, Christina;
Elias, Anthony

Publication type:

Article

HER-2 Positivity Rates in Advanced Gastric Cancer: Results From a Large International Phase Ill Trial.

Published in:

2008

By:

Bang, Y.;
Chung, H.;
Sawaki, A.

Publication type:

Abstract

COMPELLING DATA FOR TOMORROW.

Published in:

Oncology (08909091), 2008, p. 16

By:

Marshall, John L.

Publication type:

Article

HER2-Positive Breast Cancer: Remaining Challenges.

Published in:

Oncology (08909091), 2006, v. 20, n. 14, p. 1775

By:

Marcom, P. Kelly;
Verrier, Carmel S.

Publication type:

Article

Optimizing Outcomes in HER2-Positive Breast Cancer: The Molecular Rationale.

Published in:

Oncology (08909091), 2005, v. 19, p. 4

By:

Esteva, Francisco J.;
Pusztai, Lajos

Publication type:

Article

Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique.

Published in:

European Journal of Health Economics, 2014, v. 15, n. 1, p. 93, doi. 10.1007/s10198-013-0459-2

By:

Parkinson, Bonny;
Pearson, Sallie-Anne;
Viney, Rosalie

Publication type:

Article

Tailoring Chimeric Ligands for Studying and Biasing ErbB Receptor Family Interactions.

Published in:

Angewandte Chemie, 2014, v. 126, n. 10, p. 2700, doi. 10.1002/ange.201307869

By:

Krueger, Andrew T.;
Kroll, Carsten;
Sanchez, Edgar;
Griffith, Linda G.;
Imperiali, Barbara

Publication type:

Article

Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancer.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 2, p. 96, doi. 10.1007/s10147-011-0260-0

By:

Hayashi, Naoki;
Nakamura, Seigo;
Tokuda, Yasuharu;
Shimoda, Yuji;
Yagata, Hiroshi;
Yoshida, Atsushi;
Ota, Hidekazu;
Hortobagyi, Gabriel;
Cristofanilli, Massimo;
Ueno, Naoto

Publication type:

Article

High recurrence risk and use of adjuvant trastuzumab in patients with small, HER2-positive, node-negative breast cancers.

Published in:

International Journal of Clinical Oncology, 2012, v. 17, n. 2, p. 131, doi. 10.1007/s10147-011-0269-4

By:

Horio, Akiyo;
Fujita, Takashi;
Hayashi, Hironori;
Hattori, Masaya;
Kondou, Naoto;
Yamada, Mai;
Adachi, Eri;
Ushio, Aya;
Gondou, Naomi;
Sueta, Aiko;
Yatabe, Yasushi;
Iwata, Hiroji

Publication type:

Article

A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment.

Published in:

International Journal of Clinical Oncology, 2010, v. 15, n. 6, p. 615, doi. 10.1007/s10147-010-0093-2

By:

Shigematsu, Hideo;
Nakamura, Yoshiaki;
Tanaka, Kimihiro;
Shiotani, Satoko;
Koga, Chinami;
Kawaguchi, Hidetoshi;
Nishimura, Sumiko;
Taguchi, Kenichi;
Nishiyama, Kenichi;
Ohno, Shinji

Publication type:

Article

Highly efficient production of anti-HER2 scFv antibody variant for targeting breast cancer cells.

Published in:

Applied Microbiology & Biotechnology, 2011, v. 91, n. 3, p. 613, doi. 10.1007/s00253-011-3306-3

By:

Sommaruga, Silvia;
Lombardi, Alessio;
Salvadè, Agnese;
Mazzucchelli, Serena;
Corsi, Fabio;
Galeffi, Patrizia;
Tortora, Paolo;
Prosperi, Davide

Publication type:

Article

Drug response to HER2 gatekeeper T798M mutation in HER2-positive breast cancer.

Published in:

Amino Acids, 2016, v. 48, n. 2, p. 487, doi. 10.1007/s00726-015-2102-2

By:

Meng, Xuli;
Li, Yongfeng;
Tang, Hongchao;
Mao, Weimin;
Yang, Hongjian;
Wang, Xiaojia;
Ding, Xianfeng;
Xie, Shangnao

Publication type:

Article

Alternative preprocessing of RNA-Sequencing data in The Cancer Genome Atlas leads to improved analysis results.

Published in:

Bioinformatics, 2015, v. 31, n. 22, p. 3666, doi. 10.1093/bioinformatics/btv377

By:

Rahman, Mumtahena;
Jackson, Laurie K.;
Johnson, W. Evan;
Li, Dean Y.;
Bild, Andrea H.;
Piccolo, Stephen R.

Publication type:

Article

Modeling time-dependent transcription effects of HER2 oncogene and discovery of a role for E2F2 in breast cancer cell-matrix adhesion.

Published in:

Bioinformatics, 2014, v. 30, n. 21, p. 3036, doi. 10.1093/bioinformatics/btu400

By:

Bollig-Fischer, Aliccia;
Marchetti, Luca;
Mitrea, Cristina;
Wu, Jiusheng;
Kruger, Adéle;
Manca, Vincenzo;
Drăghici, Sorin

Publication type:

Article

Impact of Low HER2 Expression on Neoadjuvant Treatment Response in Early Luminal Breast Cancer.

Published in:

Zagazig University Medical Journal, 2024, v. 30, n. 8, p. 4355, doi. 10.21608/zumj.2024.313346.3524

By:

Mohamed, Amrallah A.;
Elfaragy, Ola M.;
Erfan Abdelwahab, Fatma Mohamed;
Abdelrahman, Aziza E.

Publication type:

Article

Concordance of HER2 Expression in Paired Primary and Metastatic Sites of Endometrial Serous Carcinoma and the Effect of Intratumoral Heterogeneity.

Published in:

Journal of Molecular Pathology, 2024, v. 5, n. 3, p. 405, doi. 10.3390/jmp5030027

By:

Yap, Francis Hong Xin;
Wilson, Yancey;
Peverall, Joanne;
Amanuel, Benhur;
Allanson, Ben;
Ruba, Sukeerat

Publication type:

Article

Quantitative Measurement of HER2/neu Oncogene Amplification and p53 Tumor Suppressor Gene Deletion by RT-PCR in Breast Cancer.

Published in:

Experimed, 2023, v. 13, n. 3, p. 257, doi. 10.26650/experimed.1374959

By:

Ulfer, Gozde

Publication type:

Article

Apoptosis-inducing anti-HER2 agents operate through oligomerization-induced receptor immobilization.

Published in:

Communications Biology, 2021, v. 4, n. 1, p. 1, doi. 10.1038/s42003-021-02253-4

By:

Stüber, Jakob C.;
Richter, Christian P.;
Bellón, Junel Sotolongo;
Schwill, Martin;
König, Iwo;
Schuler, Benjamin;
Piehler, Jacob;
Plückthun, Andreas

Publication type:

Article

Parental loss at age birth to 21 years and daughters' breast cancer and tumor characteristics.

Published in:

JNCI Cancer Spectrum, 2025, v. 9, n. 2, p. 1, doi. 10.1093/jncics/pkaf004

By:

Keeler, Corinna;
Krigbaum, Nickilou Y;
Cohn, Barbara;
Cirillo, Piera

Publication type:

Article

Multimodal MRI for Estimating Her-2 Gene Expression in Endometrial Cancer.

Published in:

Bioengineering (Basel), 2023, v. 10, n. 12, p. 1399, doi. 10.3390/bioengineering10121399

By:

Li, Xiwei;
Tian, Shifeng;
Ma, Changjun;
Chen, Lihua;
Qin, Jingwen;
Wang, Nan;
Lin, Liangjie;
Liu, Ailian

Publication type:

Article

Effective suppression of tumour cells by oligoclonal HER2-targeted delivery of liposomal doxorubicin.

Published in:

Journal of Liposome Research, 2019, v. 29, n. 1, p. 53, doi. 10.1080/08982104.2018.1430829

By:

Farasat, Alireza;
Rahbarizadeh, Fatemeh;
Ahmadvand, Davoud;
Ranjbar, Saeed;
Khoshtinat Nikkhoi, Shahryar

Publication type:

Article

Bilateral breast cancers in an Asian population, and a comparison between synchronous and metachronous tumours.

Published in:

ANZ Journal of Surgery, 2018, v. 88, n. 10, p. 982, doi. 10.1111/ans.14773

By:

Sim, Yirong;
Tan, Veronique K. M.;
Sidek, Nur A. B.;
Chia, Daryl K. A.;
Tan, Benita K. T.;
Madhukumar, Preetha;
Yong, Wei Sean;
Wong, Chow Yin;
Ong, Kong Wee

Publication type:

Article

Effect of rapamycin on mRNA expression of IL-8 and CXCR1 in HER2+ breast cancer cells.

Published in:

Turkish Journal of Immunology, 2016, v. 4, p. 62

By:

Şirin, Burcu;
Gedik, Mustafa Emre;
Haznedaroğlu, Elif;
Doğan, Ayşe Lale

Publication type:

Article

Prediction of HER2 status in breast cancer patients based on DCE-MRI imaging features combined Ki-67 and VEGF expression.

Published in:

European Journal of Gynaecological Oncology, 2025, v. 46, n. 2, p. 71, doi. 10.22514/ejgo.2025.022

By:

Zhiliang Huang;
Tingting Qu

Publication type:

Article

Human epidermal growth factor receptor 2 amplification as a biomarker for treatment in patients with lymph node-metastatic penoscrotal extramammary Paget's disease.

Published in:

Oncology Letters, 2019, v. 17, n. 3, p. 2677

By:

Lu, Xiaolin;
Zhang, Peipei;
Zhu, Yao;
Ye, Dingwei

Publication type:

Article

FGFR1 and HER1 or HER2 co‑amplification in breast cancer indicate poor prognosis.

Published in:

Oncology Letters, 2018, v. 15, n. 6, p. 8206, doi. 10.3892/ol.2018.8423

By:

ChEN, Shinan;
Qiu, Yan;
Guo, PENg;
Pu, Tianjie;
FENg, Ye;
Bu, Hong

Publication type:

Article

ZEB1 is involved in regulating HER2-positive breast cancer radiosensitivity by controlling EMT.

Published in:

Oncology Letters, 2018, v. 15, n. 5, p. 6851, doi. 10.3892/ol.2018.7906

By:

FUSHI HAN;
HUIYUAN ZHU;
JINMING XU;
WEI SHUI;
XIAOLING LU

Publication type:

Article

Elevated microRNA-125b levels predict a worse prognosis in HER2-positive breast cancer patients.

Published in:

Oncology Letters, 2017, v. 13, n. 2, p. 867, doi. 10.3892/ol.2016.5482

By:

YANWEI LUO;
XINYE WANG;
WEIHONG NIU;
HERAN WANG;
QIUYUAN WEN;
SONGQING FAN;
RAN ZHAO;
ZHENG LI;
WEI XIONG;
SHUPING PENG;
ZHAOYANG ZENG;
XIAOLING LI;
GUIYUAN LI;
MING TAN;
MING ZHOU

Publication type:

Article

HER2 overexpression reverses the relative resistance of EGFR-mutant H1975 cell line to gefitinib.

Published in:

Oncology Letters, 2016, v. 12, n. 6, p. 5363, doi. 10.3892/ol.2016.5373

By:

JING XU;
LI SHEN;
BI-CHENG ZHANG;
WEN-HONG XU;
SHU-QIN RUAN;
CHI PAN;
QI-CHUN WEI

Publication type:

Article

Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer.

Published in:

Oncology Letters, 2016, v. 11, n. 3, p. 2305, doi. 10.3892/ol.2016.4188

By:

BARCZAK, WOJCIECH;
ROZWADOWSKA, NATALIA;
ROMANIUK, ALEKSANDRA;
LIPIŃSKA, NATALIA;
LISIAK, NATALIA;
GRODECKA-GAZDECKA, SYLWIA;
KSIĄŻEK, KRZYSZTOF;
RUBIŚ, BŁAŻEJ

Publication type:

Article

Genetic alterations of HER genes in chromophobe renal cell carcinoma.

Published in:

Oncology Letters, 2016, v. 11, n. 3, p. 2111, doi. 10.3892/ol.2016.4198

By:

WEN HUI WENG;
YING TZU CHEN;
KAI JIE YU;
YING HSU CHANG;
CHENG KENG CHUANG;
SEE TONG PANG

Publication type:

Article

Circulating microRNA profile predicts disease progression in patients receiving second-line treatment of lapatinib and capecitabine for metastatic pancreatic cancer.

Published in:

Oncology Letters, 2016, v. 11, n. 3, p. 1645, doi. 10.3892/ol.2016.4101

By:

TIAN, XUEFEI;
SHIVAPURKAR, NARAYAN;
ZHENG WU;
HWANG, JIMMY J.;
PISHVAIAN, MICHAEL J.;
WEINER, LOUIS M.;
LEY, LISA;
DAN ZHOU;
ZHI, XIULING;
WELLSTEIN, ANTON;
MARSHALL, JOHN L.;
HE, AIWU RUTH

Publication type:

Article

Putative cancer-initiating stem cells in cell culture models for molecular subtypes of clinical breast cancer.

Published in:

Oncology Letters, 2015, v. 10, n. 6, p. 3840, doi. 10.3892/ol.2015.3780

By:

TELANG, NITIN

Publication type:

Article

Trastuzumab increases the sensitivity of HER2-amplified human gastric cancer cells to oxaliplatin and cisplatin by affecting the expression of telomere-associated proteins.

Published in:

Oncology Letters, 2015, v. 9, n. 2, p. 999, doi. 10.3892/ol.2014.2793

By:

YONGPING LIU;
YANG LING;
QIUFENG QI;
MING ZHU;
MEIZHEN WAN;
YAPING ZHANG;
CHANGSONG ZHANG

Publication type:

Article

Imaging of HER2 may improve the outcome of external irradiation therapy for prostate cancer patients.

Published in:

Oncology Letters, 2015, v. 9, n. 2, p. 950, doi. 10.3892/ol.2014.2760

By:

ANDERSSON, JENNIE;
ROSESTEDT, MARIA;
ORLOVA, ANNA

Publication type:

Article

Evaluation of chromosome 17 polysomy in breast cancer by FISH analysis of whole nuclei, and its clinicopathological significance.

Published in:

Oncology Letters, 2014, v. 7, n. 6, p. 1954, doi. 10.3892/ol.2014.2001

By:

HUIYONG JIANG;
XIAOYAN BAI;
FANJUN MENG;
CHENG ZHANG;
XUEFENG ZHANG

Publication type:

Article

HER2 status in advanced gastric carcinoma: A retrospective multicentric analysis from Sicily.

Published in:

Oncology Letters, 2013, v. 6, n. 6, p. 1591, doi. 10.3892/ol.2013.1611

By:

IENI, A.;
BARRESI, V.;
GIUFFRÈ, G.;
CARUSO, R. A.;
LANZAFAME, S.;
VILLARI, L.;
SALOMONE, E.;
ROZ, E.;
CABIBI, D.;
FRANCO, V.;
CERTO, G.;
LABATE, A.;
NAGAR, C.;
MAGLIOLO, E.;
BROGGI, B.;
FAZZARI, C.;
ITALIA, F.;
TUCCARI, G.

Publication type:

Article

Amplification and clinicopathological significance of HER-2 in Kazakh esophageal squamous cell carcinoma.

Published in:

Molecular & Clinical Oncology, 2020, v. 13, n. 5, p. N.PAG, doi. 10.3892/mco.2020.2134

By:

Muhetaer, Aishanjiang;
Niyaz, Madiniyet;
Ainiwaer, Julaiti;
Liwei, Zhang;
Awut, Edris

Publication type:

Article

Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?

Published in:

2016

By:

Yamada, Takeshi;
Yamamoto, Yoshiyuki;
Moriwaki, Toshikazu;
Hyodo, Ichisnosuke

Publication type:

commentary

Reply to the letter by Takeshi Yamada et al. concerning "Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?".

Published in:

2016

By:

Zhou, Jun;
Peng, Zhi;
Shen, Lin

Publication type:

commentary

Erratum to: Predictive value of serum HER2 ECD in patients with HER2-positive advanced gastric cancer treated with trastuzumab plus chemotherapy.

Published in:

2016

By:

Zhou, Jun;
Peng, Zhi;
Liu, Yi;
Gong, Jifang;
Zhang, Xiaotian;
Lu, Ming;
Gao, Jing;
Li, Yili;
Li, Yanyan;
Shen, Lin

Publication type:

corrected article

Evaluation of serum HER2-ECD levels in patients with gastric cancer.

Published in:

Journal of Gastroenterology, 2015, v. 50, n. 1, p. 41, doi. 10.1007/s00535-014-0941-3

By:

Oyama, Katsunobu;
Fushida, Sachio;
Tsukada, Tomoya;
Kinoshita, Jun;
Watanabe, Toshifumi;
Shoji, Masatoshi;
Nakanuma, Shinichi;
Okamoto, Koichi;
Sakai, Seisho;
Makino, Isamu;
Nakamura, Keishi;
Hayashi, Hironori;
Inokuchi, Masafumi;
Nakagawara, Hisatoshi;
Miyashita, Tomoharu;
Tajima, Hidehiro;
Takamura, Hiroyuki;
Ninomiya, Itasu;
Kitagawa, Hirohisa;
Fujimura, Takashi

Publication type:

Article

Is 'liquid biopsy' useful for assessing HER2 status in gastric cancer?

Published in:

2015

By:

Shimada, Hideaki

Publication type:

Editorial

Targeting ErbB-2 nuclear localization and function inhibits breast cancer growth and overcomes trastuzumab resistance.

Published in:

Oncogene, 2015, v. 34, n. 26, p. 3413, doi. 10.1038/onc.2014.272

By:

Cordo Russo, R I;
Béguelin, W;
Díaz Flaqué, M C;
Proietti, C J;
Venturutti, L;
Galigniana, N;
Tkach, M;
Guzmán, P;
Roa, J C;
O'Brien, N A;
Charreau, E H;
Schillaci, R;
Elizalde, P V

Publication type:

Article

A novel function of HER2/Neu in the activation of G2/M checkpoint in response to γ-irradiation.

Published in:

Oncogene, 2015, v. 34, n. 17, p. 2215, doi. 10.1038/onc.2014.167

By:

Yan, Y;
Hein, A L;
Greer, P M;
Wang, Z;
Kolb, R H;
Batra, S K;
Cowan, K H

Publication type:

Article

PRKACA mediates resistance to HER2-targeted therapy in breast cancer cells and restores anti-apoptotic signaling.

Published in:

Oncogene, 2015, v. 34, n. 16, p. 2061, doi. 10.1038/onc.2014.153

By:

Moody, S E;
Schinzel, A C;
Singh, S;
Izzo, F;
Strickland, M R;
Luo, L;
Thomas, S R;
Boehm, J S;
Kim, S Y;
Wang, Z C;
Hahn, W C

Publication type:

Article

Heterogeneity in ERK activity as visualized by in vivo FRET imaging of mammary tumor cells developed in MMTV-Neu mice.

Published in:

Oncogene, 2015, v. 34, n. 8, p. 1051, doi. 10.1038/onc.2014.28

By:

Kumagai, Y;
Naoki, H;
Nakasyo, E;
Kamioka, Y;
Kiyokawa, E;
Matsuda, M

Publication type:

Article

HER2/Neu tumorigenesis and metastasis is regulated by E2F activator transcription factors.

Published in:

Oncogene, 2015, v. 34, n. 2, p. 217, doi. 10.1038/onc.2013.540

By:

Andrechek, E R

Publication type:

Article

c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer.

Published in:

Oncogene, 2014, v. 33, n. 30, p. 3992, doi. 10.1038/onc.2013.368

By:

Nair, R;
Roden, D L;
Teo, W S;
McFarland, A;
Junankar, S;
Ye, S;
Nguyen, A;
Yang, J;
Nikolic, I;
Hui, M;
Morey, A;
Shah, J;
Pfefferle, A D;
Usary, J;
Selinger, C;
Baker, L A;
Armstrong, N;
Cowley, M J;
Naylor, M J;
Ormandy, C J

Publication type:

Article